Waters (WAT)
(Delayed Data from NYSE)
$305.31 USD
+4.48 (1.49%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $305.53 +0.22 (0.07%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$305.31 USD
+4.48 (1.49%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $305.53 +0.22 (0.07%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Zacks News
Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.
Waters (WAT) Expands Portfolio With New Mass Spectrometer
by Zacks Equity Research
Waters (WAT) unveils the Xevo TQ Absolute IVD Mass Spectrometer for Clinical Analyte Detection, which enables low-volume clinical sample testing.
Zacks Industry Outlook Highlights Mettler-Toledo International and Waters
by Zacks Equity Research
Mettler-Toledo International and Waters have been highlighted in this Industry Outlook article.
2 Instruments Stocks to Watch From a Challenging Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Waters (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Waters (WAT) Launches Alliance iS, Expands HPLC Offerings
by Zacks Equity Research
Waters (WAT) unveils HPLC System called Alliance iS to strengthen the liquid chromatography instruments business.
Waters (WAT) Expands TA Segment Offerings With New Solution
by Zacks Equity Research
Waters (WAT) unveils its Battery Cycler Microcalorimeter Solution to strengthen its TA instrument division.
Waters (WAT) Down 6.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q4 Earnings Surpass Estimates, Sales Rise Y/Y
by Zacks Equity Research
Waters' (WAT) fourth-quarter results reflect gains from strong momentum across the industrial end and strong performances in the Americas.
Waters (WAT) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 2.67% and 3.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) fourth-quarter 2022 results are likely to reflect strength in liquid chromatography instruments and mass spectrometers, and solid end-market momentum.
PerkinElmer (PKI) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
PerkinElmer (PKI) delivered earnings and revenue surprises of 2.41% and 1.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Mettler-Toledo (MTD) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 4.04% and 3.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Waters (WAT) Could Beat Earnings Estimates Again
by Zacks Equity Research
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights ASML Holding, Impinj, MSCI, Udemy and Waters
by Zacks Equity Research
ASML Holding, Impinj, MSCI, Udemy and Waters are part of the Zacks top Analyst Blog.
5 Technology Stocks Set to Top Estimates This Earnings Season
by Shilpa Mete
Here's a sneak peek into five technology stocks, which hold the potential to surpass fourth-quarter 2022 estimates.
Zacks Industry Outlook Highlights Mettler-Toledo, PerkinElmer and Waters
by Zacks Equity Research
Mettler-Toledo, PerkinElmer and Waters have been highlighted in this Industry Outlook article.
3 Instruments Stocks to Watch From a Challenging Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand despite lingering effects of COVID-19.
Why Is PerkinElmer (PKI) Up 10.3% Since Last Earnings Report?
by Zacks Equity Research
PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Up 17.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q3 Earnings Surpass Estimates, Sales Rise Y/Y
by Zacks Equity Research
Waters' (WAT) third-quarter results reflect gains from strong momentum across the industrial, government and academic end markets.
Waters (WAT) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 2.72% and 4.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) third-quarter 2022 results are likely to reflect the impacts of product portfolio strength and large molecule momentum.
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Waters (WAT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Mettler-Toledo, PerkinElmer and Waters
by Zacks Equity Research
Mettler-Toledo, PerkinElmer and Waters have been highlighted in this Industry Outlook article.
Waters (WAT) to Attract Scientists With Extraction+ Device
by Zacks Equity Research
Waters (WAT) unveils the Extraction+ Connected Device for the Waters Andrew+ Pipetting Robot. The device automates solid phase extraction methods, saving bench time for each sample set.